Bon Natural Life Limited (BON) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 22, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Jan 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BON SEC filings page.
Bon Natural Life Limited (BON) reported $18.7M in revenue for fiscal year 2025, down 21.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Bon’s smaller, lower-margin operation expanded its balance sheet while relying mainly on financing rather than operating cash generation.
From FY2024 to FY2025, revenue fell to$18.7M while SG&A rose to$4.3M , so the downturn was amplified by costs that did not contract with sales. Yet operating cash flow moved from-$7.7M to$141K and free cash flow turned positive at$134K , indicating the cash squeeze eased without restoring profitable operations—an important earnings-quality divergence.
Gross margin fell from
Assets rose to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Bon Natural Life Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Bon Natural Life Limited has an operating margin of -8.7%, meaning the company loses $9 on every $100 of revenue. This results in a profitability score of 35/100. This is down from 7.9% the prior year.
Bon Natural Life Limited's revenue declined 21.7% year-over-year, from $23.8M to $18.7M. This contraction results in a growth score of 4/100.
Bon Natural Life Limited carries a low D/E ratio of 0.01, meaning only $0.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 87/100, indicating a strong balance sheet with room for future borrowing.
Bon Natural Life Limited's current ratio of 1.74 indicates adequate short-term liquidity, earning a score of 51/100. The company can meet its near-term obligations, though with limited headroom.
Bon Natural Life Limited's free cash flow margin of 0.7% results in a low score of 13/100. Capital expenditures of $7K absorb a large share of operating cash flow.
Bon Natural Life Limited posts a -3.5% return on equity (ROE), meaning it loses $3 for every $100 of shareholders' equity. This results in a returns score of 38/100. This is down from 0.9% the prior year.
Bon Natural Life Limited scores 0.91, below the 1.81 distress threshold. The score is pulled down most by an operating loss of $1.6M against total assets of $85.2M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Bon Natural Life Limited passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Bon Natural Life Limited reported a net loss of $2.0M while generating $141K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Bon Natural Life Limited reported an operating loss of $1.6M against $366K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Bon Natural Life Limited generated $18.7M in revenue in fiscal year 2025. This represents a decrease of 21.7% from the prior year.
Bon Natural Life Limited's EBITDA was -$536K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 118.0% from the prior year.
Bon Natural Life Limited reported a net loss of $2.0M in fiscal year 2025. This represents a decrease of 601.0% from the prior year.
Bon Natural Life Limited earned -$0.72 per diluted share (EPS) in fiscal year 2025.
Cash & Balance Sheet
Bon Natural Life Limited generated $134K in free cash flow in fiscal year 2025, representing cash available after capex. The change from the prior year is not meaningful, because that figure was zero or negative.
Bon Natural Life Limited held $6.3M in cash against $843K in long-term debt as of fiscal year 2025, with $26.3M of liabilities due within a year.
Not reported for fiscal year 2025.
Margins & Returns
Bon Natural Life Limited's gross margin was 20.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 9.1 percentage points from the prior year.
Bon Natural Life Limited's operating margin was -8.7% in fiscal year 2025, reflecting core business profitability. This is down 16.6 percentage points from the prior year.
Bon Natural Life Limited's net profit margin was -10.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 12.3 percentage points from the prior year.
Bon Natural Life Limited's ROE was -3.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.4 percentage points from the prior year.
Capital Allocation
Bon Natural Life Limited invested $754K in research and development in fiscal year 2025. This represents a decrease of 53.5% from the prior year.
Bon Natural Life Limited invested $7K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 3.1% from the prior year.
Not reported for fiscal year 2025.
BON Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F |
|---|---|---|---|---|---|---|---|
| Revenue | $18.7M-21.7% | $23.8M-19.2% | $29.5M-1.3% | $29.9M+17.3% | $25.5M+39.9% | $18.2M+11.1% | $16.4M |
| Cost of Revenue | $14.8M-11.6% | $16.7M-19.1% | $20.7M+1.0% | $20.5M+11.4% | $18.4M+41.2% | $13.0M+17.1% | $11.1M |
| Gross Profit | $3.9M-45.4% | $7.1M-19.6% | $8.8M-6.2% | $9.4M+32.5% | $7.1M+36.7% | $5.2M-1.5% | $5.3M |
| R&D Expenses | $754K-53.5% | $1.6M+443.0% | $298K-29.7% | $425K+70.5% | $249K+21.3% | $205K-60.7% | $523K |
| SG&A Expenses | $4.7M+31.3% | $3.6M+38.8% | $2.6M+8.6% | $2.4M+64.1% | $1.5M-4.4% | $1.5M-3.5% | $1.6M |
| Operating Income | -$1.6M-186.6% | $1.9M-68.4% | $5.9M-10.0% | $6.6M+22.2% | $5.4M+55.7% | $3.5M+9.2% | $3.2M |
| EBITDA | -$536K-118.0% | $3.0M-56.7% | $6.9M+1.1% | $6.8M+21.1% | $5.6M+52.2% | $3.7M+8.7% | $3.4M |
| Interest Expense | $366K+20.7% | $303K+27.3% | $238K-46.7% | $447K+7.1% | $417K+26.8% | $329K-1.2% | $333K |
| Income Tax | $339K-3.4% | $351K-65.0% | $1.0M-20.9% | $1.3M+54.3% | $821K+47.6% | $556K+30.2% | $427K |
| Net Income | -$2.0M-601.0% | $398K-91.3% | $4.6M-26.3% | $6.2M+35.9% | $4.6M+51.7% | $3.0M+17.6% | $2.6M |
| EPS (Basic) | -$0.72 | $4.17 | $125.72 | $7.47 | $0.69+19.0% | $0.58+16.0% | $0.50 |
| EPS (Diluted) | -$0.72 | $4.14 | $124.92 | $7.43 | $0.68+17.2% | $0.58+16.0% | $0.50 |
| Diluted Shares (Avg) | 3M | 96,114 | 36,792 | 839,606 | 7M+28.7% | 5M+0.9% | 5M |
BON Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F |
|---|---|---|---|---|---|---|---|
| Total Assets | $85.2M+37.9% | $61.8M+32.7% | $46.6M+25.0% | $37.3M+2.3% | $36.4M+44.5% | $25.2M | N/A |
| Current Assets | $45.8M+15.0% | $39.8M+64.5% | $24.2M+64.3% | $14.7M-11.1% | $16.5M+52.7% | $10.8M | N/A |
| Cash & Equivalents | $6.3M+7687.1% | $80K-28.6% | $113K-86.6% | $841K-55.8% | $1.9M+3485.0% | $53K | N/A |
| Short-Term Investments | $0n/m | $0-100.0% | $65n/m | $0-100.0% | $1.7Mn/m | $0 | N/A |
| Inventory | $3.3M+110.2% | $1.6M+59.2% | $987K-42.7% | $1.7M+7.9% | $1.6M+57.1% | $1.0M | N/A |
| Accounts Receivable | $11.0M-6.5% | $11.8M+156.0% | $4.6M-32.2% | $6.8M+10.3% | $6.2M+6.6% | $5.8M | N/A |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0 | N/A |
| Total Liabilities | $27.2M+56.1% | $17.4M+64.7% | $10.6M+47.6% | $7.2M-27.5% | $9.9M-30.3% | $14.2M | N/A |
| Current Liabilities | $26.3M+60.0% | $16.4M+71.1% | $9.6M+44.6% | $6.6M-11.7% | $7.5M-35.6% | $11.7M | N/A |
| Non-Current Liabilities | $879K-9.3% | $970K+0.7% | $963K+86.3% | $517K-78.0% | $2.3M-5.4% | $2.5M | N/A |
| Long-Term Debt | $843K-13.1% | $970K+11.3% | $871K+359.1% | $190K-91.3% | $2.2M-12.4% | $2.5M | N/A |
| Total Equity | $57.6M+31.1% | $43.9M+23.7% | $35.5M+20.0% | $29.6M+13.7% | $26.0M+147.3% | $10.5M | N/A |
| Retained Earnings | $16.6M-11.3% | $18.7M+0.2% | $18.7M+27.4% | $14.7M+59.7% | $9.2M+81.2% | $5.1M | N/A |
Not reported in any period shown, so not listed: Goodwill.
BON Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $141Kn/m | -$7.7Mn/m | -$617Kn/m | -$187K-104.6% | $4.1M+53.3% | $2.6M-62.8% | $7.1M |
| Depreciation & Amortization | $1.1M-1.8% | $1.1M+16.0% | $955K+336.8% | $219K-4.4% | $229K-0.9% | $231K+1.7% | $227K |
| Stock-Based Compensation | $1.4M+5.6% | $1.3M+277.7% | $349K+104.5% | $171K-59.5% | $422K+100.0% | $211K | N/A |
| Capital Expenditures | $7K-3.1% | $7K-88.6% | $62K+123.5% | $28K-46.6% | $52K+62.7% | $32K-85.1% | $214K |
| Free Cash Flow | $134Kn/m | -$7.7Mn/m | -$679Kn/m | -$215K-105.4% | $4.0M+53.2% | $2.6M-62.1% | $6.9M |
| Investing Cash Flow | -$10.0Mn/m | -$16Kn/m | -$1.2Mn/m | -$3.1Mn/m | -$7.4Mn/m | -$3.0Mn/m | -$8.4M |
| Financing Cash Flow | $15.5M+76.5% | $8.8M+657.9% | $1.2M-48.9% | $2.3M-57.7% | $5.4M+4658.3% | $112K-86.0% | $805K |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
BON Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F |
|---|---|---|---|---|---|---|---|
| Gross Margin | 20.8%-9.1pp | 29.8%-0.1pp | 29.9%-1.6pp | 31.5%+3.6pp | 27.9%-0.6pp | 28.5%-3.7pp | 32.2% |
| Operating Margin | -8.7%-16.6pp | 7.9%-12.3pp | 20.1%-2.0pp | 22.1%+0.9pp | 21.2%+2.1pp | 19.0%-0.3pp | 19.4% |
| Net Margin | -10.7%-12.3pp | 1.7%-13.9pp | 15.6%-5.3pp | 20.9%+2.8pp | 18.0%+1.4pp | 16.6%+0.9pp | 15.7% |
| Return on Equity | -3.5%-4.4pp | 0.9%-12.0pp | 13.0%-8.1pp | 21.1%+3.5pp | 17.6%-11.1pp | 28.8% | N/A |
| Return on Assets | -2.3%-3.0pp | 0.6%-9.2pp | 9.9%-6.9pp | 16.7%+4.1pp | 12.6%+0.6pp | 12.0% | N/A |
| Current Ratio | 1.74-0.7x | 2.42-0.1x | 2.52+0.3x | 2.210.0x | 2.20+1.3x | 0.93 | N/A |
| Debt-to-Equity | 0.010.0x | 0.020.0x | 0.020.0x | 0.01-0.1x | 0.08-0.2x | 0.24 | N/A |
| Liabilities-to-Equity | 0.47+0.1x | 0.40+0.1x | 0.30+0.1x | 0.24-0.1x | 0.38-1.0x | 1.35 | N/A |
| Asset Turnover | 0.22-0.2x | 0.39-0.2x | 0.63-0.2x | 0.80+0.1x | 0.700.0x | 0.72 | N/A |
| FCF Margin | 0.7%+33.1pp | -32.4%-30.1pp | -2.3%-1.6pp | -0.7%-16.4pp | 15.7%+1.4pp | 14.3%-27.7pp | 42.0% |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Bon Natural Life Limited BON | FY2025 | $18.7M | -$2.0M | -10.7% | $9.4M | 38/100 |
| CN Energy Group Inc. CNEY | FY2025 | $35.6M | -$11.1M | -31.3% | $2.6M | 53/100 |
| BOLT PROJECTS HLDGS INC BSLK | FY2024 | $1.4M | N/A | N/A | N/A | — |
| BioNexus Gene Lab Corp BGLC | FY2025 | $7.4M | -$3.0M | -40.2% | $3.5M | 43/100 |
| SenesTech, Inc. SNES | FY2025 | $2.2M | -$6.4M | N/A | $4.2M | 63/100 |
| Northern Technologies International Corp. NTIC | FY2025 | $84.2M | $18K | 0.0% | $72.6M | 51/100 |
Where Bon Natural Life Limited Ranks
Frequently Asked Questions
What is Bon Natural Life Limited's annual revenue?
Bon Natural Life Limited (BON) reported $18.7M in total revenue for fiscal year 2025. This represents a -21.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Bon Natural Life Limited's revenue growing?
Bon Natural Life Limited (BON) revenue declined by 21.7% year-over-year, from $23.8M to $18.7M in fiscal year 2025.
Is Bon Natural Life Limited profitable?
No, Bon Natural Life Limited (BON) reported a net loss of $2.0M in fiscal year 2025, with a net profit margin of -10.7%.
What is Bon Natural Life Limited's EBITDA?
Bon Natural Life Limited (BON) had EBITDA of -$536K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Bon Natural Life Limited have?
As of fiscal year 2025, Bon Natural Life Limited (BON) had $6.3M in cash and equivalents against $843K in long-term debt.
What is Bon Natural Life Limited's gross margin?
Bon Natural Life Limited (BON) had a gross margin of 20.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Bon Natural Life Limited's operating margin?
Bon Natural Life Limited (BON) had an operating margin of -8.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Bon Natural Life Limited's net profit margin?
Bon Natural Life Limited (BON) had a net profit margin of -10.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Bon Natural Life Limited's return on equity (ROE)?
Bon Natural Life Limited (BON) has a return on equity of -3.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Bon Natural Life Limited's free cash flow?
Bon Natural Life Limited (BON) generated $134K in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Bon Natural Life Limited's operating cash flow?
Bon Natural Life Limited (BON) generated $141K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Bon Natural Life Limited's total assets?
Bon Natural Life Limited (BON) had $85.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Bon Natural Life Limited's capital expenditures?
Bon Natural Life Limited (BON) invested $7K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Bon Natural Life Limited spend on research and development?
Bon Natural Life Limited (BON) invested $754K in research and development during fiscal year 2025.
What is Bon Natural Life Limited's current ratio?
Bon Natural Life Limited (BON) had a current ratio of 1.74 as of fiscal year 2025, which is generally considered healthy.
What is Bon Natural Life Limited's debt-to-equity ratio?
Bon Natural Life Limited (BON) had a debt-to-equity ratio of 0.01 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Bon Natural Life Limited's liabilities-to-equity ratio?
Bon Natural Life Limited (BON) had a liabilities-to-equity ratio of 0.47 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Bon Natural Life Limited's return on assets (ROA)?
Bon Natural Life Limited (BON) had a return on assets of -2.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Bon Natural Life Limited's P/E ratio?
Bon Natural Life Limited (BON) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $9.4M as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Bon Natural Life Limited's price-to-sales ratio?
Bon Natural Life Limited (BON) trades at 0.5x sales, its market capitalization divided by $18.7M revenue, FY2025. The market capitalization is $9.4M as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Bon Natural Life Limited's Altman Z-Score?
Bon Natural Life Limited (BON) has an Altman Z-Score of 0.91, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Bon Natural Life Limited's Piotroski F-Score?
Bon Natural Life Limited (BON) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Bon Natural Life Limited's earnings high quality?
Bon Natural Life Limited (BON) reported a net loss of $2.0M while generating $141K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Bon Natural Life Limited cover its interest payments?
Bon Natural Life Limited (BON) reported an operating loss of $1.6M against $366K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Bon Natural Life Limited?
Bon Natural Life Limited (BON) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.